Purchase Order 7571TE26P00040

This is a firm-fixed price purchase order contract awarded to Chemical Computing Group ULC, doing business as Groupe Informatique Chemical, by the U.S. Environmental Protection Agency's Office of Research and Development. The $70,000.00 contract is for the provision of software licenses for the Molecular Operating Environment (MOE), a molecular modeling and simulation platform used to support drug design and related research across various federal agencies. The contract has an ultimate...

The Food and Drug Administration awarded a purchase order to Global Life Sciences Solutions USA LLC for $51,400 on June 25, 2026, for mechanistic chromatography modeling software license support and maintenance. Work is performed in Silver Spring, Maryland through June 24, 2027. The order covers a one-year software license and support package for GoSilico or equivalent mechanistic chromatography modeling software, including a graphical interface with drag-and-drop functionality, AKTA system...

<p>The Food and Drug Administration issued a purchase order to Schrodinger LLC on June 27, 2023, for a Small Molecule Drug Discovery Suite license with a ceiling value of $248,024.00. Work is performed in Portland, Oregon. The firm fixed-price order extends through July 30, 2028.</p>

The Environmental Protection Agency Office of Research and Development awarded a firm fixed price purchase order valued at fifty-five thousand three hundred fifty dollars ($55,350) to Chemical Computing Group ULC for the annual software license of the Molecular Operating Environment (MOE) modeling software. The license provides five tokens of the molecular modeling and simulation platform to support EPA research through January 18, 2024. No set-aside designation was applied to this procurement...

This is a firm fixed-price purchase order for $547,097.40 awarded by the National Library of Medicine (part of the U.S. Department of Health and Human Services) to Openeye Scientific Software, Inc. for software maintenance and licensing of the company's proprietary molecular modeling and cheminformatics programming toolkits. The award supports critical research and development efforts in pharmaceutical and biomedical fields, enabling advanced computational chemistry capabilities utilized by...

The Department of Health and Human Services' Food and Drug Administration awarded a $157,134 firm fixed price delivery order contract to Regan Technologies Corporation. This order is placed against Solutions for Enterprise-Wide Procurement V, a government-wide acquisition contract vehicle, to provide CLC BIO software licenses. The place of performance is Silver Spring, Maryland. The one-year contract begins on September 27, 2023 and concludes on September 29, 2024. As the FDA works to protect...

<p>The Food and Drug Administration issued a delivery order to Cority Software Inc. on July 6, 2022, with a ceiling value of $808,491.58 for Cority licenses and consulting services, under the GSA Multiple Award Schedule (MAS).</p> <p>Place of performance is Silver Spring, Maryland. The order ultimate completion date is July 6, 2024. Work is priced on a firm fixed-price basis with no set-aside designation.</p>

The Food and Drug Administration awarded a firm fixed price purchase order valued at one hundred seventy-one thousand seven hundred thirty-three dollars to Chemotargets S.l. to deliver a pharmacological mechanism-based safety prediction platform. As described in the original solicitation, FDA/Center for Drug Evaluation and Research sought a tool to predict potential secondary targets for new pharmaceuticals through data mining and analytics of chemical properties. The place of performance will...

This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services (HHS), to Openeye Scientific Software, Inc. The contract is for the renewal of software licenses and support for Openeye's proprietary molecular modeling and cheminformatics software tools, such as SZMAP, FILTER, ROCS, and OEDocking. The contract has a period of performance from September 16, 2015, to...

The U.S. Food and Drug Administration (FDA) awarded a Total Small Business set-aside purchase order to Certara USA Inc. for biopharmaceutical in vitro in vivo correlation and mechanistic modeling assessments software licenses. The contract, valued at $18,200, was awarded on September 19, 2022, with a completion date of September 20, 2023, and is structured as a firm fixed price purchase order. Performance of this work will occur in Calverton, Maryland. Certara USA Inc. is a leading biosimulation...